ACCP Research

 

christine.berni@accesspharma.com

www.AccessPharma.com

2600 Stemmons Freeway
Suite 176
Dallas, TX 75207
P: 214.905.5100
F: 214.905.5101


 

Research Report| Presentation Downloads:

Access Pharma: Griffin Securities 7/30/09

Access Pharma: NextWave 12/16/09

Access Pharma: January 2010 Presentation

Disclaimer

Contact Us

Access Pharma Blog

Current Articles | RSS Feed RSS Feed

Access Pharma (OTCBB: ACCP) - Zacks Confirms $8 Price Target

Access Pharma's (ACCP) - Updated Stock Video Chart

Access Pharma's (ACCP) $30 million deal with RHEI Pharmaceuticals

Access Pharma (ACCP) Launches MuGard Product Website

Initial Order for MuGard at Access Pharma (OTCBB: ACCP)

Access Pharma (OTCBB: ACCP) and Michael Douglas' Cancer

OutsideIn Research - Q&A with Jeff Davis of Access Pharma (OTCBB: ACCP) - Part II

Access Pharma (OTCBB: ACCP) - ACCP Tech Trade Video

OutsideIn Research - Q&A with Jeff Davis of Access Pharma (OTCBB: ACCP) - Part 1

Zacks Issues Update on their "Outperform" Research Report on Access Pharmaceuticals (OTCBB: ACCP)

Access Pharma (OTCBB: ACCP) - Rita Biotech on Phase I/II Clinical Trial at UT MD Anderson Cancer Center

MuGard Fact Sheet Update for Access Pharmaceuticals (OTCBB: ACCP)

Access Pharmaceuticals (OTCBB: ACCP) Updates on MuGard Launch and Clinical Development Program of Thiarabine

Access Pharmaceuticals (OTCBB:ACCP) to Host North American MuGard Commercialization Update Conference Call On August 3rd for Investors

Zacks Issues "Outperform" Research Report on Access Pharmaceuticals (OTCBB: ACCP)

Access Pharmaceuticals (OTCBB: ACCP) Signs Exclusive Specialty Distribution Agreement With BioScrip

Access Pharmaceuticals (OTCBB: ACCP) Signs Agreement With Major Biotech Company to Develop Oral Formulations of Leading Injectable Drug

Access Pharma (OTCBB: ACCP) Initiates U.S. MuGard Sampling Program With Leading Oncology Groups #ProActiveNR

Access Pharma (OTCBB: ACCP) Presents at the California NanoSystems Institute Conference Focused on Targeted Delivery of RNAi Therapeutics

Access Pharmaceuticals ($ACCP) - CorporateProfile.com interviewed CEO Jeff Davis - #ProActiveNR

Access Pharma to Present European MuGard Post-Marketing Data

Access Pharma to Present, Meet with Investors in London

$ACCP.OB: Collaborators Validate Oral Delivery of Insulin in Preclinical Studies

Access Pharma (OTC: ACCP.OB) CEO Audio Interview

Access Pharma (OTCBB: ACCP) Reports Completion of First North American MuGard Commercial Production Run

Access Pharma (OTCBB:ACCP) Announces Collaboration with Leading Oral Mucositis Doctor

CEO Jeffrey Davis of Access Pharma (OTC: ACCP.OB)

ACCP Landing Page

accp proactive

ACCP @ Yahoo! Finance News

Access Pharmaceuticals To Host Investor Call On Wednesday, May 23, 2012
Wednesday, May 16, 2012
ACCESS PHARMACEUTICALS INC Files SEC form 10-Q, Quarterly Report
Tue, 15 May 2012 20:34:43 GMT
UPDATE: 9th Annual Taglich Brothers Small Cap Equity Conference
Mon, 23 Apr 2012 18:28:00 GMT
[Marketwire] - NEW YORK, NY-- - The 9th Annual Taglich Brothers Small Cap...Read More
9th Annual Taglich Brothers Small Cap Equity Conference
Mon, 23 Apr 2012 13:30:00 GMT
[Marketwire] - NEW YORK, NY-- - The 9th Annual Taglich Brothers Small Cap...Read More
Access Pharmaceuticals, Inc. to Present at Taglich Brothers 9th Annual Small Cap Equity Conference
Thu, 19 Apr 2012 13:30:00 GMT
Access Pharmaceuticals Announces Interim Data From MuGard Phase 4 Clinical Trial in Oral Mucositis
Monday, Apr 16, 2012
Access Pharmaceuticals MuGard on Formulary at Memorial Sloan-Kettering Cancer Center
Tuesday, Apr 3, 2012
REMINDER: Access Pharmaceuticals Investor Call Tomorrow, Wednesday April 4th at 11AM ET
Monday, Apr 2, 2012

Twitter @accesspharma

Accesspharma: Thanks to the great people at Community Specialty Pharmacy Network (CSPN) for their great work with MuGard. #cancer #pharmacy
Thu, 17 May 2012 16:37:31 +0000
Accesspharma: See MuGard testimonials, about mucositis treatment, at http://t.co/To6D2tdq. #cancer @AmericanCancer @Livestrong
Thu, 17 May 2012 16:12:50 +0000
Accesspharma: Got mucositis? Try MuGard ... see http://t.co/HjHash6p for details
Thu, 17 May 2012 15:43:02 +0000